MedSchool: Ace Your OSCEsThe Medical Company
GET - On the App Store
Drug Guide


  • Mechanism of Action

  • Reversibly inhibits factor IIa (thrombin), resulting in reduced fibrin clot formation.
  • Pharmacology

  • Idarucizumab (praxbind) may be used to reverse dabigatran in life-threatening situations only.

Clinical Use

  • Indications
  • Prevention of venous thromboembolism post hip / knee surgery
  • Treatment of venous thromboembolism (DVT / PE)
  • Non-valvular atrial fibrillation (prevention of stroke)
  • Contraindications
  • Active bleeding or risk of major bleeding
  • Use of other anticoagulants
  • Mechanical heart valve
  • Severe renal impairment (eGFR
  • Adverse Effects
  • Haemorrhage
  • Oesophageal ulceration
  • Monitoring

  • A dilute thrombin time assay may be used to monitor dabigatran.
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now

Snapshot: Initialising...